We use cookies for a better user experience. Read our Privacy Policy
I Agree
Viral Clearance Service Market
The global viral clearance service market was valued at US$ 261.9 Mn in 2017 and is anticipated to reach US$ 902.1 Mn by 2026, expanding at a CAGR of 14.9% from 2018 to 2026. Increase in demand for detection of virus removal/inactivation in products during their early stages of development, rise in R&D expenditure, growing preference for outsourcing of viral clearance service to contract research organizations, rise in consumer awareness about safety associated with the use of health care and vaccines, and increase in concern of viral effects of blood-derived products are some factors boosting the demand for viral clearance service. Moreover, emergence of technologies, such as nanofilteration and chromatography services, and choice of choosing the method depends on type of product, process, and regulatory. The user would need to determine the level of virus clearance required (as per logarithmic reduction) before marketing approval of new molecules. Companies have started focusing on efficacy and quality with high investments in R&D owing to stringent restructuring of regulations by both U.S. FDA and the European Medicines Agency that have put in place requirements for viral safety in relation to biologics. This has ultimately helped boost the viral clearance service market.
The viral clearance service market is witnessing robust expansion owing to increasing complexity of clinical trials, greater number of regulatory hurdles, and high investment required for infrastructure that results in greater clinical trials cost. Consequently, rising number of pharmaceutical companies are partnering with viral clearance service providers having the requisite infrastructure and expertise to manage costs and deadlines. Moreover, increasing focus on specialty drugs is likely to fuel the market, as specialty drugs require scientific expertise and highly tailored clinical trials that significantly increase costs.
The viral clearance service market has been segmented based on application, method, end-user, and region. In terms of applications, the recombinant proteins segment is estimated to account for a prominent share of the market. Rising prevalence of diseases, such as cardiovascular, diabetes, and oncological, robust pipeline of pharmaceutical and biopharmaceutical products, increasing expenditure on research and development, rising emphasis on innovative treatment therapies for existing as well upcoming diseases, increasing demand for outsourcing analytical testing, and optimal service provided by the viral clearance service provider companies are major factors driving the global viral clearance service market.
In terms of method, the global viral clearance services has been classified into viral removal and viral inactivation method. The viral removal segment leads the market and accounts for a major share, as it is a robust and effective method of removal of different types of viruses. It is also expensive, safe, and brings about a high degree of purity of sample. The viral inactivation segment has been further sub-segmented into chemical, radiation, and others such as pasteurization and dry and moist heat treatment.
In terms of end-user, the global viral clearance service market has been categorized into biopharmaceuticals, contract research organizations, academic research institutes and other end-users. The biopharmaceuticals segment held a major market share in 2017. This can be attributed to the rise in R&D expenditure of these industries, increased outsourcing of clinical studies to contract research organizations that enables them to manage R&D costs and focus on their core competencies, and increase in pressure from regulatory agencies for viral removal/inactivation process in order to prove product safety to obtain market approval.
In terms of region, the global viral clearance service market has been categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global viral clearance services market due to the presence of a large number of viral clearance removal/inactivation service providers, high health care spending, and stringent regulations governing safety assessment of biologics and vaccines. Europe follows North America in terms of share of the market, which can be ascribed to the amendment of regulation made by governments in Europe in order to assess the safety of biological substances. The market in Asia Pacific is projected to expand at a significant CAGR during the forecast period owing to the emergence of CROs offering viral clearance services, as per regulatory requirements at a lower cost than that in other developed regions.
Prominent players operating in the global viral clearance service market include Texcell, Eurofins Scientific SE, Charles River Laboratories International, Inc., Merck KGaA (BioReliance), WuXi AppTec, Clean Cells, and Vironova Biosafety. Key players are expanding their product portfolio through mergers & acquisitions and partnerships & collaborations with leading pharmaceutical and biotechnology companies and by providing better services at a lower cost.
Growing Need for Safe Drug Development to Bring Tremendous Growth Opportunities for the Viral Clearance Service Market
The viral clearance service market is expected to gain good growth opportunities across the assessment period of 2018-2026 on the back of the rising demand for virus detection in specialty drugs and biological products. The growing demand for virus inactivation among a large number of drugs and biological products may bring extensive growth opportunities for the viral clearance service market.
The global viral clearance service market has been segmented as follows:
|
by Application |
|
|
by Method |
|
|
by End-user |
|
|
by Region |
|
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions
2.2. Research Methodology
3. Executive Summary : Global Viral Clearance Service
3.1.Global Viral Clearance Service Market Value (US$ Mn) and Distribution, by Geography, 2017 and 2026
3.2. Global Viral Clearance Service Market Snapshot, 2017
3.3. Global Viral Clearance Service Market: Opportunity Map
4. Market Overview
4.1. Introduction
4.1.1. Application Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.1.1. Increased outsourcing of viral clearance testing studies
4.3.1.2. Rise in R&D expenditure
4.3.1.3. Rise in focus on early clearance of virus in biologics
4.3.1.4. Increased burden of regulatory requirements
4.3.1.5. Technological advancements
4.3.1.6. Growing economies of the world
4.3.2. Restraints
4.3.2.1. Reduction of preclinical outsourcing budget by some of the large pharma companies
4.3.2.2. High cost and complexity involved in the development and approval of biologics and biosimilars
4.3.3. Opportunities
4.4. Global Viral Clearance Service Market Analysis and Forecast, 2016–2026
4.4.1. Global Viral Clearance Service Market Value (US$ Mn) Forecast
4.5. Porter’s Five Force Analysis
5. Market Outlook
5.1. Regulatory Scenario by Region/globally
5.2. Key Mergers & Acquisitions
5.3. Technological Advancements
5.4. Key Market Trends
5.5. Competitive Landscape Analysis (based on strategic developments of players)
5.6. Future Prospects Assessment
6. Global Viral Clearance Service Market Analysis and Forecast, by Application
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Viral Clearance Service Market Value Forecast, by Application, 2016–2026
6.3.1. Recombinant Proteins
6.3.2. Tissue and Blood Derived Products
6.3.3. Vaccines
6.3.4. Others
6.4. Global Viral Clearance Service Market Attractiveness, by Application
7. Global Viral Clearance Service Analysis and Forecast, by Method
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Viral Clearance Service Market Value Forecast, by Method, 2016–2026
7.3.1. Viral Removal
7.3.2. Viral Inactivation
7.3.2.1. Chemical
7.3.2.2. Radiation
7.3.2.3. Other
7.4. Global Viral Clearance Service Market Attractiveness, by Method
8. Global Viral Clearance Service Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Viral Clearance Service Market Value Forecast, by End-user, 2016–2026
8.3.1. Biopharmaceuticals
8.3.2. Contract Research Organizations
8.3.3. Academic Research Institutes
8.3.4. Other End-users
8.4. Global Viral Clearance Service Market Attractiveness by End-user
9. Global Viral Clearance Service Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global Viral Clearance Service Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Viral Clearance Service Market Attractiveness, by Region
10. North America Viral Clearance Service Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America Viral Clearance Service Market Value Forecast, by Application, 2016–2026
10.2.1. Recombinant Proteins
10.2.2. Tissue and Blood Derived Products
10.2.3. Vaccines
10.2.4. Others
10.3. North America Viral Clearance Service Market Value Forecast, by Method, 2016–2026
10.3.1. Viral Removal
10.3.2. Viral Inactivation
10.3.2.1. Chemical
10.3.2.2. Radiation
10.3.2.3. Other
10.4. North America Viral Clearance Service Market Value Forecast, by End-user, 2016–2026
10.4.1. Biopharmaceuticals
10.4.2. Contract Research Organizations
10.4.3. Academic Research Institutes
10.4.4. Other End-users
10.5. North America Viral Clearance Service Market Value Forecast, by Country, 2016–2026
10.5.1. U.S.
10.5.2. Canada
10.6. North America Viral Clearance Service Market Attractiveness Analysis
10.6.1. By Application
10.6.2. By Method
10.6.3. By End-user
10.6.4. By Country
11. Europe Viral Clearance Service Analysis and Forecast
11.1.Introduction
11.1.1. Key Findings
11.2. Europe Viral Clearance Service Market Value Forecast, by Application, 2016–2026
11.2.1. Recombinant Proteins
11.2.2. Tissue and Blood Derived Products
11.2.3. Vaccines
11.2.4. Others
11.3. Europe Viral Clearance Service Market Value Forecast, by Method, 2016–2026
11.3.1. Viral Removal
11.3.2. Viral Inactivation
11.3.2.1. Chemical
11.3.2.2. Radiation
11.3.2.3. Other
11.4. Europe Viral Clearance Service Market Value Forecast, by End-user, 2016–2026
11.4.1. Biopharmaceuticals
11.4.2. Contract Research Organizations
11.4.3. Academic Research Institutes
11.4.4. Other End-users
11.5. Europe Viral Clearance Service Market Value Forecast, by Country/Sub-region, 2016–2026
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Viral Clearance Service Market Attractiveness Analysis
11.6.1. By Application
11.6.2. By Method
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Viral Clearance Service Analysis and Forecast
12.1.Introduction
12.1.1. Key Findings
12.2. Asia Pacific Viral Clearance Service Market Value Forecast, by Application, 2016–2026
12.2.1. Recombinant Proteins
12.2.2. Tissue and Blood Derived Products
12.2.3. Vaccines
12.2.4. Others
12.3. Asia Pacific Viral Clearance Service Market Value Forecast, by Method, 2016–2026
12.3.1. Viral Removal
12.3.2. Viral Inactivation
12.3.2.1. Chemical
12.3.2.2. Radiation
12.3.2.3. Other
12.4. Asia Pacific Viral Clearance Service Market Value Forecast, by End-user, 2016–2026
12.4.1. Biopharmaceuticals
12.4.2. Contract Research Organizations
12.4.3. Academic Research Institutes
12.4.4. Other End-users
12.5. Asia Pacific Viral Clearance Service Market Value Forecast, by Country/Sub-region, 2016–2026
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Viral Clearance Service Market Attractiveness Analysis
12.6.1. By Application
12.6.2. By Method
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Viral Clearance Service Analysis and Forecast
13.1.Introduction
13.1.1. Key Findings
13.2. Latin America Viral Clearance Service Market Value Forecast, by Application, 2016–2026
13.2.1. Recombinant Proteins
13.2.2. Tissue and Blood Derived Products
13.2.3. Vaccines
13.2.4. Others
13.3. Latin America Viral Clearance Service Market Value Forecast, by Method, 2016–2026
13.3.1. Viral Removal
13.3.2. Viral Inactivation
13.3.2.1. Chemical
13.3.2.2. Radiation
13.3.2.3. Other
13.4. Latin America Viral Clearance Service Market Value Forecast, by End-user, 2016–2026
13.4.1. Biopharmaceuticals
13.4.2. Contract Research Organizations
13.4.3. Academic Research Institutes
13.4.4. Other End-users
13.5. Latin America Viral Clearance Service Market Value Forecast, by Country/Sub-region, 2016–2026
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Viral Clearance Service Market Attractiveness Analysis
13.6.1. By Application
13.6.2. By Method
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Viral Clearance Service Analysis and Forecast
14.1.Introduction
14.1.1. Key Findings
14.2. Middle East & Africa Viral Clearance Service Market Value Forecast, by Application, 2016–2026
14.2.1. Recombinant Proteins
14.2.2. Tissue and Blood Derived Products
14.2.3. Vaccines
14.2.4. Others
14.3. Middle East & Africa Viral Clearance Service Market Value Forecast, by Method, 2016–2026
14.3.1. Viral Removal
14.3.2. Viral Inactivation
14.3.2.1. Chemical
14.3.2.2. Radiation
14.3.2.3. Other
14.4. Middle East & Africa Viral Clearance Service Market Value Forecast, by End-user, 2016–2026
14.4.1. Biopharmaceuticals
14.4.2. Contract Research Organizations
14.4.3. Academic Research Institutes
14.4.4. Other End-users
14.5. Middle East & Africa Viral Clearance Service Market Value Forecast, by Country/Sub-region, 2016–2026
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Viral Clearance Service Market Attractiveness Analysis
14.6.1. By Application
14.6.2. By Method
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Global Viral Clearance Service Market Player – Competition Matrix (by Tier and Size of companies)
15.2. Global Viral Clearance Service Market Share Analysis, by Company (2017)
15.3. Competitive Business Strategies
15.4. Company Profiles
15.4.1. Texcell
15.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.1.2. Company Financials
15.4.1.3. Growth Strategies
15.4.1.4. Recent Events
15.4.1.5. SWOT Analysis
15.4.2. Eurofins Scientific SE
15.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.2.2. Company Financials
15.4.2.3. Growth Strategies
15.4.2.4. Recent Events
15.4.2.5. SWOT Analysis
15.4.3. Charles River Laboratories International, Inc.
15.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.3.2. Company Financials
15.4.3.3. Growth Strategies
15.4.3.4. Recent Events
15.4.3.5. SWOT Analysis
15.4.4. Merck KGaA (BioReliance)
15.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.4.2. Company Financials
15.4.4.3. Growth Strategies
15.4.4.4. Recent Events
15.4.4.5. SWOT Analysis
15.4.5. WuXi AppTec
15.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.5.2. Company Financials
15.4.5.3. Growth Strategies
15.4.5.4. Recent Events
15.4.5.5. SWOT Analysis
15.4.6. Clean Cells
15.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.6.2. Company Financials
15.4.6.3. Growth Strategies
15.4.6.4. Recent Events
15.4.6.5. SWOT Analysis
15.4.7. Vironova Biosafety
15.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.7.2. Company Financials
15.4.7.3. Growth Strategies
15.4.7.4. Recent Events
15.4.7.5. SWOT Analysis
List of Tables
Table 01: Global Viral Clearance Service Market Value (US$ Mn) Forecast, 2016–2026
Table 02: Global Viral Clearance Service Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 03: Global Viral Clearance Service Market Value (US$ Mn) Forecast, by Method, 2016–2026
Table 04: Global Viral Clearance Service Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 05: Global Viral Clearance Service Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 06: North America Viral Clearance Service Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 07: North America Viral Clearance Service Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 08: North America Viral Clearance Service Market Value (US$ Mn) Forecast, by Method, 2016–2026
Table 09: North America Viral Clearance Service Market Value (US$ Mn) Forecast, by Viral Inactivation, 2016–2026
Table 10: North America Viral Clearance Service Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 11: Europe Viral Clearance Service Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 12: Europe Viral Clearance Service Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 13: Europe Viral Clearance Service Market Value (US$ Mn) Forecast, by Method, 2016–2026
Table 14: Europe Viral Clearance Service Market Value (US$ Mn) Forecast, by Viral Inactivation, 2016–2026
Table 15: Europe Viral Clearance Service Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 16: Asia Pacific Viral Clearance Service Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 17: Asia Pacific Viral Clearance Service Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 18: Asia Pacific Viral Clearance Service Market Value (US$ Mn) Forecast, by Method, 2016–2026
Table 19: Asia Pacific Viral Clearance Service Market Value (US$ Mn) Forecast, by Viral Inactivation, 2016–2026
Table 20: Asia Pacific Viral Clearance Service Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 21: Latin America Viral Clearance Service Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 22: Latin America Viral Clearance Service Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 23: Latin America Viral Clearance Service Market Value (US$ Mn) Forecast, by Method, 2016–2026
Table 24: Latin America Viral Clearance Service Market Value (US$ Mn) Forecast, by Viral Inactivation, 2016–2026
Table 25: Latin America Viral Clearance Service Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 26: Middle East & Africa Viral Clearance Service Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 27: Middle East & Africa Viral Clearance Service Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 28: Middle East & Africa Viral Clearance Service Market Value (US$ Mn) Forecast, by Method, 2016–2026
Table 29: Middle East & Africa Viral Clearance Service Market Value (US$ Mn) Forecast, by Viral Inactivation, 2016–2026
Table 30: Middle East & Africa Viral Clearance Service Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 31: Competition Matrix
List of Figures
Figure 01: Global Viral Clearance Service Market Value (US$ Mn) and Distribution, by Region, 2017 and 2026
Figure 02: Global Viral Clearance Service Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 03: Global Viral Clearance Service Market Value Share, by Application, 2017 and 2026
Figure 04: Global Viral Clearance Service Market Value (US$ Mn) and Y-o-Y Growth (%), by Recombinant Proteins, 2016–2026
Figure 05: Global Viral Clearance Service Market Value (US$ Mn) and Y-o-Y Growth (%), by Tissue and Blood Derived Products, 2016–2026
Figure 06: Global Viral Clearance Service Market Value (US$ Mn) and Y-o-Y Growth (%), by Vaccines, 2016–2026
Figure 07: Global Viral Clearance Service Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 08: Global Viral Clearance Service Market Attractiveness Analysis, by Application, 2018–2026
Figure 09: Global Viral Clearance Service Market Value Share, by Method, 2017 and 2026
Figure 10: Global Viral Clearance Service Market Value (US$ Mn) and Y-o-Y Growth (%), by Viral Removal , 2016–2026
Figure 11: Global Viral Clearance Service Market Value (US$ Mn) and Y-o-Y Growth (%), by Viral Inactivation, 2016–2026
Figure 12: Global Viral Clearance Service Market Attractiveness Analysis, by Method, 2018–2026
Figure 13: Global Viral Clearance Service Market Value Share, by End-user, 2017 and 2026
Figure 14: Global Viral Clearance Service Market Value (US$ Mn) and Y-o-Y Growth (%), by Biopharmaceuticals, 2016–2026
Figure 15: Global Viral Clearance Service Market Value (US$ Mn) and Y-o-Y Growth (%), by Contract Research Organizations, 2016–2026
Figure 16: Global Viral Clearance Service Market Value (US$ Mn) and Y-o-Y Growth (%), by Academic Research Institutes, 2016–2026
Figure 17: Global Viral Clearance Service Market Value (US$ Mn) and Y-o-Y Growth (%), by Other End-users, 2016–2026
Figure 18: Global Viral Clearance Service Market Attractiveness Analysis, by End-user, 2018–2026
Figure 19: Global Viral Clearance Service Market Value Share, by Region, 2017 and 2026
Figure 20: Global Viral Clearance Service Market Attractiveness Analysis, by Region, 2018–2026
Figure 21: North America Viral Clearance Service Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 22: North America Viral Clearance Service Market Value Share, by Country, 2017 and 2026
Figure 23: North America Viral Clearance Service Market Attractiveness, by Country, 2018–2026
Figure 24: North America Viral Clearance Service Market Value Share, by Application, 2017 and 2026
Figure 25: North America Viral Clearance Service Market Attractiveness, by Application, 2018–2026
Figure 26: North America Viral Clearance Service Market Value Share, by Method, 2017 and 2026
Figure 27: North America Viral Clearance Service Market Attractiveness, by Method, 2018–2026
Figure 28: North America Viral Clearance Service Market Value Share, by End-user, 2017 and 2026
Figure 29: North America Viral Clearance Service Market Attractiveness, by End-user, 2018–2026
Figure 30: Europe Viral Clearance Service Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 31: Europe Viral Clearance Service Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 32: Europe Viral Clearance Service Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 33: Europe Viral Clearance Service Market Value Share, by Application, 2017 and 2026
Figure 34: Europe Viral Clearance Service Market Attractiveness, by Application, 2018–2026
Figure 35: Europe Viral Clearance Service Market Value Share, by Method, 2017 and 2026
Figure 36: Europe Viral Clearance Service Market Attractiveness, by Method, 2018–2026
Figure 37: Europe Viral Clearance Service Market Value Share, by End-user, 2017 and 2026
Figure 38: Europe Viral Clearance Service Market Attractiveness, by End-user, 2018–2026
Figure 39: Asia Pacific Viral Clearance Service Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 40: Asia Pacific Viral Clearance Service Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 41: Asia Pacific Viral Clearance Service Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 42: Asia Pacific Viral Clearance Service Market Value Share, by Application, 2017 and 2026
Figure 43: Asia Pacific Viral Clearance Service Market Attractiveness, by Application, 2018–2026
Figure 44: Asia Pacific Viral Clearance Service Market Value Share, by Method, 2017 and 2026
Figure 45: Asia Pacific Viral Clearance Service Market Attractiveness, by Method, 2018–2026
Figure 46: Asia Pacific Viral Clearance Service Market Value Share, by End-user, 2017 and 2026
Figure 47: Asia Pacific Viral Clearance Service Market Attractiveness, by End-user, 2018–2026
Figure 48: Latin America Viral Clearance Service Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 49: Latin America Viral Clearance Service Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 50: Latin America Viral Clearance Service Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 51: Latin America Viral Clearance Service Market Value Share, by Application, 2017 and 2026
Figure 52: Latin America Viral Clearance Service Market Attractiveness, by Application, 2018–2026
Figure 53: Latin America Viral Clearance Service Market Value Share, by Method, 2017 and 2026
Figure 54: Latin America Viral Clearance Service Market Attractiveness, by Method, 2018–2026
Figure 55: Latin America Viral Clearance Service Market Value Share, by End-user, 2017 and 2026
Figure 56: Latin America Viral Clearance Service Market Attractiveness, by End-user, 2018–2026
Figure 57: Middle East & Africa Viral Clearance Service Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 58: Middle East & Africa Viral Clearance Service Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 59: Middle East & Africa Viral Clearance Service Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 60: Middle East & Africa Viral Clearance Service Market Value Share, by Application, 2017 and 2026
Figure 61: Middle East & Africa Viral Clearance Service Market Attractiveness, by Application, 2018–2026
Figure 62: Middle East & Africa Viral Clearance Service Market Value Share, by Method, 2017 and 2026
Figure 63: Middle East & Africa Viral Clearance Service Market Attractiveness, by Method, 2018–2026
Figure 64: Middle East & Africa Viral Clearance Service Market Value Share, by End-user, 2017 and 2026
Figure 65: Middle East & Africa Viral Clearance Service Market Attractiveness, by End-user, 2018–2026
Figure 66: Competitive Business Strategies
Figure 67: Texcell SWOT
Figure 68: Eurofins Scientific SE SWOT
Figure 69: Charles River Laboratories International, Inc. SWOT
Figure 70: Merck KGaA (BioReliance) SWOT
Figure 66: WuXi AppTec SWOT
Figure 72: Clean Cells SWOT
Figure 73: Vironova Biosafety SWOT
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
*86 figures and 60 tables includes